United States · FDA National Drug Code directory
FONDAPARINUX SODIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55150-231_a193830a-dc25-412a-b047-d2fa77d9dbbc
- Product NDC
- 55150-231
- Form
- INJECTION, SOLUTION
- Composition / generic term
- FONDAPARINUX SODIUM
- Labeler
- Eugia US LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171226
- Source listing expiry
- 20261231
Source-listed ingredients
- FONDAPARINUX SODIUM — 5 mg/.4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE, GLASS in 1 CARTON (55150-231-02) / .4 mL in 1 SYRINGE, GLASS (55150-231-00) · 55150-231-02
- 10 SYRINGE, GLASS in 1 CARTON (55150-231-10) / .4 mL in 1 SYRINGE, GLASS (55150-231-00) · 55150-231-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →